Overview Financials News + Filings Key Docs Charts Ownership Insiders |
AMPAL-AMERICAN ISRAEL CORP (AMPL)
|
Add to portfolio |
|
|
Price: |
$50.41
| | Metrics |
OS: |
2.81
|
M
| |
|
|
Market cap: |
$141
|
M
| |
-98
|
% ROIC
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
($3.30)
| |
|
|
BVPS
|
($83.95)
| |
-0.60
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
Revenues | 575.3 | 505.0 | 431.2 | 562.5 | 39.3 | 14.5 | 21.5 | 31.5 |
Revenue growth | 13.9% | 17.1% | -23.3% | 1330.6% | 170.4% | -32.4% | -31.6% | -39.3% |
Cost of goods sold | 640.7 | 517.6 | 409.7 | 529.1 | 41.5 | 4.4 | 11.0 | 11.8 |
Gross profit | -65.3 | -12.6 | 21.4 | 33.4 | -2.2 | 10.2 | 10.6 | 19.7 |
Gross margin | -11.4% | -2.5% | 5.0% | 5.9% | -5.6% | 70.0% | 49.1% | 62.5% |
Selling, general and administrative | | | | | | | 24.1 | 52.4 |
Sales and marketing | 10.7 | 6.0 | 6.9 | 10.8 | 0.7 | | | |
General and administrative | 59.1 | 59.6 | 45.0 | 43.1 | 14.7 | 13.5 | | |
EBIT | -138.6 | -79.2 | -34.0 | 20.7 | -7.5 | -4.8 | -22.7 | -32.7 |
EBIT margin | -24.1% | -15.7% | -7.9% | 3.7% | -19.1% | -33.3% | -105.5% | -104.0% |
Pre-tax income | -135.3 | -78.3 | -30.3 | -20.5 | -17.6 | -3.4 | -13.5 | -32.7 |
Income taxes | -15.8 | 7.1 | -10.4 | -6.0 | 0.0 | -5.9 | -10.6 | -22.5 |
Tax rate | 11.6% | | 34.3% | 29.4% | 0.0% | 176.8% | 78.4% | 68.8% |
Earnings from continuing ops | -172.8 | -77.9 | -20.3 | | | 0.0 | 0.0 | -18.4 |
Earnings from discontinued ops | 34.1 | 19.9 | | | | 0.0 | | |
Net income | -138.8 | -58.0 | -20.3 | 0.0 | 0.0 | 0.0 | 0.0 | -18.4 |
Net margin | -24.1% | -11.5% | -4.7% | 0.0% | 0.0% | 0.0% | 0.0% | -58.4% |
|
Diluted EPS | ($2.10) | ($1.07) | ($0.35) | | | | | |
Shares outstanding (diluted) | 82.1 | 72.4 | 58.1 | | | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|